Investigations of methylmercury-induced alterations in neurogenesis.

Methylmercury (MeHg) has been an environmental concern to public health and regulatory agencies for over 50 years because of its toxicity to the human nervous system. Its association with nervous system toxicity in adults and infants near Minamata Bay, Japan, in the 1950s initiated environmental health research inquiries that continue to this day. Observations of greater neurotoxicity with gestational compared with adult exposure suggest a unique susceptibility of the developing nervous system to MeHg. Despite extensive research conducted over the last half century, determination of definitive molecular mechanisms underlying the observed neurotoxic effects of MeHg have not been identified. This paper summarizes results of a series of experiments conducted to examine the effects of MeHg on neuroepithelial cell proliferation, a hypothesized mode of action for its selective effects on neurogenesis. Observed effects of MeHg on cell cycle entry and progression were associated with alterations in a variety of cell cycle regulatory molecules, including p21 signaling pathways. We place these studies in the context of other cellular responses involved in signal transduction, including oxidative stress, altered protein phosphorylation, and altered intracellular calcium homeostasis. Although existing information suggests that no single mechanism underlies the diverse array of effects associated with MeHg-induced developmental neurotoxicity, we demonstrate characteristic effects of MeHg on cell signaling that contribute to observed effects on cell proliferation. Experimentally derived cell cycle kinetic and cytotoxicity data allowed development of a biologically based dose-response model of MeHg-induced alterations in neurodevelopment, which can form the basis for information synthesis and hypothesis testing and for use in assessing risks from environmental exposures.

[1]  D. Rice,et al.  Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. , 2000, Environmental health perspectives.

[2]  E. Faustman,et al.  Induction of the cell cycle regulatory gene p21 (Waf1, Cip1) following methylmercury exposure in vitro and in vivo. , 1999, Toxicology and applied pharmacology.

[3]  R. Paules,et al.  Cell cycle control, checkpoint mechanisms, and genotoxic stress. , 1999, Environmental health perspectives.

[4]  S. Orrenius,et al.  Thiol modification and cell signalling in chemical toxicity. , 1992, Toxicology letters.

[5]  W. Hughes A PHYSICOCHEMICAL RATIONALE FOR THE BIOLOGICAL ACTIVITY OF MERCURY AND ITS COMPOUNDS , 1957, Annals of the New York Academy of Sciences.

[6]  M. Aschner,et al.  Mitotic arrest in the developing CNS after prenatal exposure to methylmercury. , 1984, Neurobehavioral toxicology and teratology.

[7]  T. Clarkson,et al.  Metal toxicity in the central nervous system. , 1987, Environmental health perspectives.

[8]  L. Lapham,et al.  ABNORMAL NEURONAL MIGRATION, DERANGED CEREBRAL CORTICAL ORGANIZATION, AND DIFFUSE WHITE MATTER ASTROCYTOSIS OF HUMAN FETAL BRAIN: A MAJOR EFFECT OF METHYLMERCURY POISONING IN UTERO , 1978, Journal of neuropathology and experimental neurology.

[9]  L. Philipson,et al.  CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. , 1994, Genes & development.

[10]  A. Verhoef,et al.  The early effects of methylmercury on the developing rat brain , 2004, Acta Neuropathologica.

[11]  K. McGinnis,et al.  Methylmercury increases intracellular concentrations of Ca++ and heavy metals in NG108-15 cells. , 1993, The Journal of pharmacology and experimental therapeutics.

[12]  K. Prasad,et al.  Alterations in gene expression after chronic treatment of glioma cells in culture with methylmercuric chloride. , 1979, Biochemical pharmacology.

[13]  P. Sager Selectivity of methyl mercury effects on cytoskeleton and mitotic progression in cultured cells. , 1988, Toxicology and applied pharmacology.

[14]  S H Moolgavkar,et al.  A biologically-based dose-response model for developmental toxicology. , 1996, Risk analysis : an official publication of the Society for Risk Analysis.

[15]  K. Eto Pathology of Minamata disease. , 1997, Toxicologic pathology.

[16]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[17]  Choi Bh Methylmercury poisoning of the developing nervous system: I. Pattern of neuronal migration in the cerebral cortex. , 1986 .

[18]  N. Holbrook,et al.  Activation of the growth arrest and DNA damage-inducible gene gadd 153 by nephrotoxic cysteine conjugates and dithiothreitol. , 1992, The Journal of biological chemistry.

[19]  A. Fornace,et al.  The p53-dependent gamma-ray response of GADD45. , 1994, Cancer research.

[20]  G. Hannon,et al.  The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA , 1994, Nature.

[21]  E. Faustman,et al.  The role of intracellular glutathione in methylmercury-induced toxicity in embryonic neuronal cells. , 1999, Neurotoxicology.

[22]  M. Karin,et al.  p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes , 1994, Nature.

[23]  B. H. Choi Effects of methylmercury on neuroepithelial germinal cells in the developing telencephalic vesicles of mice , 2004, Acta Neuropathologica.

[24]  N. Herschkowitz,et al.  Brain development in the fetus, neonate and infant. , 1988, Biology of the neonate.

[25]  C. Guillouf,et al.  p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis. , 1995, Oncogene.

[26]  P. Rabinovitch,et al.  BrdU-Hoechst flow cytometry: a unique tool for quantitative cell cycle analysis. , 1988, Experimental cell research.

[27]  E. Faustman,et al.  p21(WAF1/CIP1) inhibits cell cycle progression but not G2/M-phase transition following methylmercury exposure. , 2002, Toxicology and applied pharmacology.

[28]  M. Karin,et al.  AP-1 in cell proliferation and survival , 2001, Oncogene.

[29]  B. H. Choi The effects of methylmercury on the developing brain , 1989, Progress in Neurobiology.

[30]  M. Fiscella,et al.  A p53-independent Pathway for Activation of WAF1/CIP1 Expression Following Oxidative Stress * , 1995, The Journal of Biological Chemistry.

[31]  J. Fargnoli,et al.  Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents , 1989, Molecular and cellular biology.

[32]  C. Pickart,et al.  Mechanism of ubiquitin conjugating enzyme E2-230K: catalysis involving a thiol relay? , 1996, Biochemistry.

[33]  James Brugarolas,et al.  Radiation-induced cell cycle arrest compromised by p21 deficiency , 1995, Nature.

[34]  R. Cuesta,et al.  Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. , 1999, Science.

[35]  D. Ron,et al.  CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. , 1992, Genes & development.

[36]  N. Mottet,et al.  Effects of methylmercury on the morphogenesis of the rat cerebellum. , 1986, Teratology.

[37]  E. Faustman,et al.  Biologically based dose-response models for developmental toxicants: lessons from methylmercury. , 1999, Inhalation toxicology.

[38]  M. Harada,et al.  Congenital Minamata disease: intrauterine methylmercury poisoning. , 1978, Teratology.

[39]  Bert Vogelstein,et al.  Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21 , 1996, Nature.

[40]  P. Howley,et al.  Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation , 1997, Molecular and cellular biology.

[41]  N. Mottet Effects of chronic low-dose exposure of rat fetuses to methylmercury hydroxide. , 1974, Teratology.

[42]  E. Faustman,et al.  Effects of methyl mercury on the cell cycle of primary rat CNS cells in vitro. , 1994, Toxicology and applied pharmacology.

[43]  N. Imura,et al.  Effects of methylmercury on mitotic mouse glioma cells. , 1978, Environmental research.

[44]  S. Bayer Cellular aspects of brain development. , 1989, Neurotoxicology.

[45]  M. Verity,et al.  Oxidative mechanisms underlying methyl mercury neurotoxicity , 1991, International Journal of Developmental Neuroscience.

[46]  T W Clarkson,et al.  Reproductive and developmental toxicity of metals. , 1985, Scandinavian journal of work, environment & health.

[47]  N. Mottet,et al.  The Congenital Teratogenicity and Perinatal Toxicity of Metals , 1983 .

[48]  K. Eto,et al.  Review Article: Pathology of Minamata Disease , 1997 .

[49]  B. Weiss,et al.  Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals. , 1990, Neurotoxicology and teratology.

[50]  E. Faustman,et al.  Induction of growth arrest and DNA damage-inducible genes Gadd45 and Gadd153 in primary rodent embryonic cells following exposure to methylmercury. , 1997, Toxicology and applied pharmacology.

[51]  E. Faustman,et al.  Characterization of cytoskeletal and neuronal markers in micromass cultures of rat embryonic midbrain cells , 1993, Cell Biology and Toxicology.

[52]  P. O'Connor,et al.  Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. , 1994, Science.

[53]  C. Cox,et al.  Fetal methylmercury poisoning. Relationship between concentration in single strands of maternal hair and child effects. , 1987, Archives of neurology.

[54]  M. Hochstrasser Ubiquitin-dependent protein degradation. , 1996, Annual review of genetics.

[55]  S. Elledge,et al.  p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells , 1995, Science.

[56]  E. Sausville,et al.  Proteasome inhibitors: a novel class of potent and effective antitumor agents. , 1999, Cancer research.

[57]  T. Horigome,et al.  Alterations in Gene Expression Due to Methylmercury in Central and Peripheral Nervous Tissues of the Rat , 1991 .

[58]  William D. Atchison,et al.  Mechanisms of methylmercury‐induced neurotoxicity , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[59]  W. Mundy,et al.  Sensitivity of immature neurons in culture to metal-induced changes in reactive oxygen species and intracellular free calcium. , 2000, Neurotoxicology.

[60]  W. Atchison,et al.  Methylmercury alters intrasynaptosomal concentrations of endogenous polyvalent cations. , 1993, Toxicology and applied pharmacology.

[61]  M. Berridge,et al.  Calcium signalling and cell proliferation , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[62]  T Takeuchi,et al.  FETAL MINAMATA DISEASE: A NEUROPATHOLOGICAL STUDY OF TWO CASES OF INTRAUTERINE INTOXICATION BY A METHYL MERCURY COMPOUND , 1965, Journal of neuropathology and experimental neurology.

[63]  M. Aschner,et al.  Persistent, differential alterations in developing cerebellar cortex of male and female mice after methylmercury exposure. , 1984, Brain research.

[64]  Y. Takizawa,et al.  A fetal type of Minamata disease. An autopsy case report with special reference to the nervous system. , 1992, Molecular and chemical neuropathology.

[65]  A. Fornace,et al.  DNA damage-inducible transcripts in mammalian cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[66]  M. Osame,et al.  Computed tomography in fetal methylmercury poisoning. , 1993, Journal of toxicology. Clinical toxicology.

[67]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[68]  A. Fornace,et al.  The p53-dependent γ-Ray Response of GADD45 , 1994 .

[69]  E. Mcgeer,et al.  Methylmercury poisoning of the developing nervous system in the rat: decreased activity of glutamic acid decarboxylase in cerebral cortex and neostriatum. , 1985, Brain research.

[70]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[71]  E. Wagner,et al.  Control of cell cycle progression by c-Jun is p53 dependent. , 1999, Genes & development.